2022
DOI: 10.1136/jnnp-2022-329917
|View full text |Cite
|
Sign up to set email alerts
|

High frequency ofHTRA1ANDABCC6mutations in Japanese patients with adult-onset cerebral small vessel disease

Abstract: BackgroundThis study aimed to clarify the frequency and clinical features of monogenic cerebral small vessel disease (mgCSVD) among patients with adult-onset severe CSVD in Japan.MethodsThis study included patients with adult-onset severe CSVD with an age of onset ≤55 years (group 1) or >55 years and with a positive family history (group 2). After conducting conventional genetic tests forNOTCH3andHTRA1, whole-exome sequencing was performed on undiagnosed patients. Patients were divided into two groups accor… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
4
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
5
1

Relationship

1
5

Authors

Journals

citations
Cited by 6 publications
(4 citation statements)
references
References 38 publications
0
4
0
Order By: Relevance
“…Mutations in this gene result in diseases of the immune system including Aicardi-Goutieres syndrome and other autoimmune-type diseases which can put subjects at a higher risk of ischemic stroke. Uemura 2023 investigating the prevalence of Mendelian stroke genes mutations in monogenic cerebral small vessel stroke patients aged 55 years or younger from a Japanese stroke registry identified a TREX1 pathogenic genetic variants in one stroke subject (Uemura et al 2023). A large Mendelian Stroke Consortium also identified pathogenic clinical variants in TREX1 (Grami et al 2020).…”
Section: Discussionmentioning
confidence: 99%
“…Mutations in this gene result in diseases of the immune system including Aicardi-Goutieres syndrome and other autoimmune-type diseases which can put subjects at a higher risk of ischemic stroke. Uemura 2023 investigating the prevalence of Mendelian stroke genes mutations in monogenic cerebral small vessel stroke patients aged 55 years or younger from a Japanese stroke registry identified a TREX1 pathogenic genetic variants in one stroke subject (Uemura et al 2023). A large Mendelian Stroke Consortium also identified pathogenic clinical variants in TREX1 (Grami et al 2020).…”
Section: Discussionmentioning
confidence: 99%
“…In recent years, increasing numbers of genes have been associated with cSVDs ( 8 18 ). Notably, mutations in four genes — NOTCH3 , HTRA1 (high-temperature requirement A serine peptidase 1), COL4A1 (collagen type IV α1), and COL4A2 — account for the vast majority of monogenic adult-onset cSVDs ( Table 1 ) ( 19 22 ). Among these monogenic forms, cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL), caused by dominant missense mutations that alter the number of cysteines in one of the 34 EGF repeats in the extracellular domain of the NOTCH3 protein (NOTCH3 ECD ), is the most frequent ( 23 ).…”
Section: A Continuum Between Monogenic and Multifactorial Csvdsmentioning
confidence: 99%
“…Written informed consents were obtained from the patient (proband) and her mother. Genetic testing and exome sequencing (ES) were performed as described previously [7]. Briefly, genomic DNA was extracted from the proband's blood, and Sanger sequencing analysis was performed for NOTCH3 and HTRA1.…”
Section: • Genetic Tests and Exome Sequencingmentioning
confidence: 99%